Impact of the COVID-19 pandemic on symptoms of anxiety and depression and health-related quality of life in older patients with chronic kidney disease
Nephrology Dialysis Transplantation
; 36(SUPPL 1):i310, 2021.
Article
in English
| EMBASE | ID: covidwho-1402439
ABSTRACT
BACKGROUND AND AIMS:
Older patients with advanced chronic kidney disease (CKD) are at increased risk for a severe course of the coronavirus disease-2019 (COVID-19) and vulnerable to mental health problems. We aimed to investigate prevalence and associated patient (demographic and clinical) characteristics of mental wellbeing (health-related quality of life [HRQoL] and symptoms of depression and anxiety) before and during the COVID-19 pandemic in older patients with advanced CKD.METHOD:
An ongoing Dutch multicentre prospective cohort study enrols patients of ≥70 years with an eGFR <20 mL/min/1.73m2 from October 2018 onward. With additional questionnaires during the pandemic (May-June 2020), disease-related concerns about COVID-19 and general anxiety symptoms were assessed crosssectionally, and depressive symptoms, HRQoL, and emotional symptoms longitudinally.RESULTS:
The 82 included patients had a median age of 77.5 years (inter-quartile range 73.9-82.1), 77% was male and none had tested positive for COVID-19. Crosssectionally, 67% of the patients reported to be more anxious for COVID-19 because of their kidney disease, and 43% of the patients stated that their quality of life was reduced due to the COVID-19 pandemic (Figure 1). Higher COVID-19-related stress was associated with a lower education level (p=0.036), and patients who reported to feel more down due to COVID-19 were more often female (p=0.020). Anxiety scores were higher among females compared to males (median 4.0 [IQR 3.0-9.0] versus 2.0 [0.0- 6.0], p=0.020), and weakly associated to a decline in eGFR (correlation coefficient 0.197, p=0.023). MO505 Figure 1 Respondents' agreement to the COVID-19 related statements. Questions were scored on a scale from 1 'totally disagree' to 5 'totally agree'. Mean score for question 1 was 3.6 (IQR 2.8-5.0) n=82, question 2 mean 2.7 (IQR 1.0-4.0) n=82, question 3 mean 2.3 (IQR 1.0-4.0) n=82, question 4 mean 2.7 (IQR 1.0-4.0) n=81.Compared to pre-COVID-19, presence of depressive symptoms had increased (11% to 22%;p=0.022) and physical HRQoL declined (40.4610.1 to 36.1610.4, p<0.001). Mental HRQoL (50.369.6 to 50.469.9;p=0.913) and emotional symptoms remained similar. Males showed a greater decline in physical HRQoL (mean -5.3, SD 8.5) compared to females (mean -0.9, SD 5.7;p=0.039).CONCLUSION:
Our findings show that older patients with advanced CKD suffered from disease-related anxiety for COVID-19, increased depressive symptoms, and reduced physical HRQOL during the COVID-19 pandemic. The impact of the pandemic on this vulnerable patient group extends beyond increased mortality risk, and awareness of mental health problems during the pandemic is essential. More indepth investigation on disease-related COVID-19 concerns and its implications for the CKD population is needed.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Experimental Studies
Language:
English
Journal:
Nephrology Dialysis Transplantation
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS